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Abstract
Background: Computerized dynamic posturography (CDP) has been used to detect balance and
stability impairments in adults of all ages. The goal of the current pilot study was to evaluate balance
in healthy older adults after a middle-of-the-night awakening and to assess the ability of CDP to
measure effects of bedtime zolpidem administration.
Methods: Two studies used CDP to evaluate balance in healthy older adults (≥ 65 years) during
middle-of-the-night awakenings. The first study used a drug-free, single-period, within-subject,
repeated measures study design. Subjects were evaluated during the day, pre-sleep, and 2 hours
after bedtime for dynamic standing balance using the NeuroCom EquiTest Sensory Organization
Test (SOT). Pairwise comparisons were made using one-way ANOVA. The second study was a
single-blind, randomized, placebo-controlled, crossover study evaluating the ability of the SOT to
measure medication-induced dynamic standing balance impairments using the commonly
prescribed sleep medication, zolpidem 10 mg, as a test medication. Assessments were performed
at night before zolpidem administration and then again 2 hours after bedtime. Comparisons were
made between the 2 groups using an ANCOVA model.
Results: Twelve older adults (mean age 68.4 years) were evaluated in the first study. There was
no significant difference between pre-sleep and middle-of-the-night assessments for the SOT
composite score (P = 0.439). Eleven older adults (mean age 68.9 years) were evaluated in the
second study. Zolpidem administration significantly decreased the SOT composite score after a
middle-of-the-night awakening compared with placebo (P < 0.001).
Conclusion: In healthy older adults, getting up in the middle of the night did not have a significant
effect on dynamic standing balance; however, bedtime administration of zolpidem 10 mg did lead
to significant impairments. Thus, the SOT was able to measure medication-induced dynamic
standing balance impairments and may be useful for future studies comparing balance effects of
medications.
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Background
Older adults often take medications to treat a variety of
conditions, many of which can profoundly affect balance
and stability.[1] Impaired balance and mobility in older
adults is particularly concerning since potential conse-
quences include an increased risk of falls and injuries.[2]
Many falls in older adults can be attributed to medication-
induced balance impairments. [3-5] Additionally, medi-
cations with the potential for balance impairments taken
at night may pose a significant risk for older adults since
approximately 20% of all falls are reported to occur at
night.[3]
Several classes of medication commonly prescribed to
older adults have demonstrated potential effects on bal-
ance, including the sedative-hypnotics (for insomnia),
antidepressants (for depression and anxiety), and anti-
convulsants (for seizure disorders). In older adults, several
studies have suggested that sedative-hypnotics may be
associated with impaired balance and an increased risk of
falls and hip fractures. [5-9] A retrospective case-control
study found that hip fractures occurred twice as often in
adults over the age of 65 taking zolpidem compared with
those taking no insomnia medication.[8] However, other
studies have found no increased risk for falls or hip frac-
tures in older adults taking sedative-hypnotics and
attribute balance impairments to insomnia itself.[10]
Antidepressants also have been associated with an
increased risk of falls in older adults with no significant
differences detected between the older tricyclic antide-
pressants and the newer selective serotonin reuptake
inhibitors.[11] Common side effects of anticonvulsants
include dizziness and ataxia, which may lead to impaired
balance in older adults. In a study comparing the effects of
lamotrigine, carbamazepine, and gabapentin on balance,
older adults scored below normal on multiple balance
assessments.[12]
Most medications are not routinely assessed for the possi-
bility of affecting balance and stability; however, as stated
previously, the consequences of impaired balance can be
severe in older adults. A test is needed that can detect a
medication's relative risk of balance impairment in older
adults. This would help to better identify appropriate
medications for those patients at particular risk for com-
plications due to potential mobility issues.
Computerized dynamic posturography (CDP) has been
used previously to assess balance in a variety of condi-
tions. [12-14] One specific CDP test is the NeuroCom
EquiTest Sensory Organization Test (SOT), which pro-
vides an extremely sensitive objective assessment of the
main sensory systems involved in balance and stability.
The SOT was chosen for these studies because it is a well-
recognized assessment tool that has been used extensively
to evaluate dynamic standing balance both in research
and clinical practice. [13-16]
In the current analysis, 2 separate pilot studies used the
SOT assessment to evaluate dynamic standing balance in
older adults during middle-of-the-night awakenings. In
the first study, normal healthy older adults were evaluated
after a middle-of-the-night awakening. The goal was to
establish a comparative normal balance baseline for fur-
ther studies in older adults using the SOT assessment and
to determine if getting out of bed in the middle of the
night was itself a risk factor for balance impairment. The
second study was placebo-controlled and evaluated the
ability of the SOT to determine medication-induced
dynamic standing balance impairments. Zolpidem is a
commonly prescribed medication that has been previ-
ously determined to alter balance up to 5 hours after
administration,[9] and was therefore chosen as the test
medication.
Methods
All studies were conducted in compliance with Good
Clinical Practices and applicable Federal and local laws
with Institutional Review Board approval. Informed con-
sent was obtained from all subjects prior to enrollment in
the study.
Balance assessment test (EquiTest computerized dynamic 
posturography)
The NeuroCom EquiTest SOT (NeuroCom International,
Inc., Clackamas, OR) assesses postural stability and the
potential for falls by identifying abnormalities in the sub-
ject's use of the somatosensory, visual, and vestibular sen-
sory systems that contribute to balance. The SOT
procedure requires subjects to stand on a pressure-sensi-
tive, dynamic tilted force plate facing a sway-referenced
visual surround while strapped into a safety harness to
prevent injury in the event of a loss of balance. Each test
comprises 3 trials for each of 6 conditions representing
different aspects of balance (Figure 1). For condition 1,
the subject's eyes are open, and the force plate remains in
a fixed position. This condition assesses baseline postural
stability under normal circumstances. For condition 2, the
subject's eyes are closed, and the force plate remains in a
fixed position. For condition 3, the subject's eyes are
open, the force plate remains in a fixed position, and the
visual surround is tilted. For condition 4, the subject's eyes
are open, the force plate tilts, and the visual surround
remains upright. For condition 5, the subject's eyes are
closed, and the force plate tilts. For condition 6, the sub-
ject's eyes are open, the force plate tilts, and the visual sur-
round tilts. For each condition an equilibrium score (ES1-
6) is calculated that quantifies the center of gravity sway or
postural stability under each of the 3 trials of the 6 sensory
conditions. The scores are based on the amount of ante-BMC Geriatrics 2008, 8:15 http://www.biomedcentral.com/1471-2318/8/15
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rior-posterior sway compared to the maximal theoretical
sway limits of stability (8.5° anterior and 4° posterior).
The score is calculated by the following formula: ES =
{12.5° - (θmax - θmin)}/12.5° × 100%. In this formula,
θmax  indicates the greatest anterior-posterior sway dis-
played by the subject and θmin indicates the least anterior-
posterior sway. A score of 100 represents perfect balance
(no sway), and a score of 0 represents a potential fall
(sway exceeds limits of stability). If at any time during the
test, the subject takes a step or requires the assistance of
the safety harness, the subject scores a 0 for that test. An
average score is calculated for each of the 6 conditions and
a composite equilibrium score (CES) is calculated as a
weighted average of all 6 individual scores with each of
the first 2 conditions carrying a weight of 1/14 and each
of the other 4 conditions carrying a weight of 3/14. These
weights were specified by the manufacture to reflect the
difficulty levels of the 6 tasks. Sensory analysis ratios also
are used to identify possible impairments of individual
sensory systems. The somatosensory ratio (condition 2/
condition 1), visual ratio (condition 4/condition 1), and
vestibular ratio (condition 5/condition 1) assess the abil-
ity to use input from each sensory system to control bal-
ance. The preference ratio (condition 3 + 6/condition 2 +
5) assesses the extent upon which a subject relies on visual
input to control balance, even when the visual informa-
tion is incorrect. The SOT has been used in many previous
studies and has been shown to be a valid assessment of
balance impairment in older adults and accurately pre-
dicts fall risk.[13,14,17]
Balance assessment of healthy older adults after a middle-
of-the-night awakening
This study evaluated CDP balance assessments using a
drug-free, single-period, within-subject, repeated meas-
ures study design. Subjects eligible for the study were
Six Conditions of the EquiTest Sensory Organization Test Assess Postural Stability and Potential for Falls Figure 1
Six Conditions of the EquiTest Sensory Organization Test Assess Postural Stability and Potential for Falls. Fig-
ure Used Courtesy of NeuroCom® International, Inc.BMC Geriatrics 2008, 8:15 http://www.biomedcentral.com/1471-2318/8/15
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healthy adults, aged 65 or older, with no history of insom-
nia, psychiatric disorder, significant medical condition
(unless controlled with protocol-allowed medication), or
balance impairment. Subjects were asked about any his-
tory of recurrent falls, recent serious head injuries, pres-
ence of an inner ear or vestibular system disorder, history
of dizziness, or any significant visual acuity or field abnor-
malities not improved with the use of corrective lenses to
detect any possible undiagnosed balance impairments.
Subjects were not allowed to participate if they had taken
any medications known to affect sleep-wake functions or
alter the central nervous system, or if they participated in
a clinical trial of an investigational drug within 1 week (or
5 half-lives) of the start of the study. Subjects were
screened 4–10 days prior to testing, which included docu-
mentation of medical history, sleep history (including
habitual bedtime), and a physical examination. Subjects
were also exposed to the EquiTest CDP tests to acclimate
them to the testing procedures and assess their daytime
SOT scores. On the day of testing, subjects reported to the
clinic 2 hours prior to habitual bedtime and were allowed
to relax in a private room. After 30 minutes, a pre-sleep
assessment of the SOT was performed as described above.
Subjects went to sleep at their habitual bedtime. After 2
hours, subjects were awakened and completed the SOT
procedure again. Each SOT assessment consisted of 3 tri-
als for each condition. Following middle-of-the-night
testing, subjects returned to bed and were allowed to sleep
until morning (8 hours after bedtime). Subjects left the
clinic in the morning after a brief neurological exam.
Descriptive statistics were used to summarize the SOT
results at daytime, pre-sleep, and after the middle-of-the-
night awakening. Pairwise comparisons were made using
one-way ANOVA with the time of day as a class effect. A P
value less than 0.05 was considered statistically signifi-
cant.
Effect of zolpidem on balance assessment of healthy older 
adults after a middle-of-the-night awakening
This study evaluated the ability of CDP to detect medica-
tion-induced balance impairments using a single-blind,
randomized, placebo-controlled, crossover study design
with zolpidem as the test medication. Healthy older
adults (≥ 65 years of age) with no history of sleep or bal-
ance disorders were included in this study. The subjects
enrolled in this study were not the same as those enrolled
in the first, drug-free study. Subjects were excluded from
the study if they had a history of a psychiatric disorder or
significant medical condition (unless controlled with pro-
tocol-allowed medication), had taken any medications
known to affect sleep-wake functions or alter the central
nervous system, or if they participated in a clinical trial of
an investigational drug within 1 week (or 5 half-lives) of
the start of the study. Subjects with a history of recurrent
falls, recent serious head injuries, presence of an inner ear
or vestibular system disorder, history of dizziness, or any
significant visual acuity or field abnormalities not
improved with the use of corrective lenses were excluded
from the study. At initial screening (between Days -7 and
-1), medical histories were obtained, and subjects under-
went a physical exam, 12-lead electrocardiogram, and
CDP assessments. On the first crossover treatment day
(Day 1), subjects arrived at the clinic 2 hours before habit-
ual bedtime, and a pre-sleep assessment for the SOT was
obtained. Immediately prior to bedtime, subjects were
randomly assigned to receive either zolpidem 10 mg or
placebo. Subjects were awakened after 2 hours for middle-
of-the-night SOT balance assessment. After balance test-
ing, subjects were allowed to go back to sleep until morn-
ing (8 hours after bedtime). Subjects were required to
remain at the clinic until noon to assess potential residual
sedation. On the second crossover treatment day
(between Days 4 and 7), subjects followed the same pro-
cedures and were assigned to receive the opposite treat-
ment as their first visit (zolpidem 10 mg or placebo).
Adverse events (AEs) were monitored throughout the
study.
Descriptive statistics were used to summarize the SOT
results for the placebo and zolpidem 10 mg groups. Com-
parisons were made between the 2 groups using an
ANCOVA with sequence, period, and treatment group as
class effects and the pre-treatment baseline measurement
as a continuous covariate. A P value less than 0.05 was
considered statistically significant.
Results
Balance assessment of healthy older adults after a middle-
of-the-night awakening
A total of 12 older adults (1 man, 11 women, age range 65
– 80 years, average age 68.4 years) completed the study.
Results for the SOT assessment are shown in Table 1.
There was no significant difference between the daytime
or pre-sleep assessments and the middle-of-the-night
assessment for the composite equilibrium score or any of
the individual equilibrium scores for the SOT. There were
also no detected impairments in any of the ratios (soma-
tosensory, visual, vestibular, or preference) designed to
evaluate sensory system function.
Effect of zolpidem on balance assessment of healthy older 
adults after a middle-of-the-night awakening
A total of 11 older adults (3 men, 8 women, age range 65
– 81 years, average age 68.9 years) were enrolled in the
crossover study, with 1 subject discontinuing after the first
treatment period (only completed zolpidem 10 mg treat-
ment). Pre-sleep baseline assessments (before medication
administration) showed no significant differences
between the placebo and zolpidem groups on any of theBMC Geriatrics 2008, 8:15 http://www.biomedcentral.com/1471-2318/8/15
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SOT equilibrium scores or SOT sensory ratios (P > 0.05 for
both) and were within normal limits for older adults. The
differences between the placebo and zolpidem middle-of-
the-night SOT assessment is shown in Table 2. Bedtime
zolpidem administration resulted in a significant decrease
in the composite equilibrium score after a middle-of-the-
night awakening compared with placebo (P < 0.001). The
vestibular ratio was also significantly decreased after
zolpidem treatment compared with placebo (P < 0.002).
Out of 11 subjects, 1 AE occurred during the placebo
phase (headache) and 2 AEs occurred during the zolpi-
dem phase (upper respiratory infection and headache).
The 2 occurrences of headache were deemed possibly
related to study drug while the upper respiratory infection
was deemed unrelated to study drug. All AEs were consid-
ered mild.
Discussion
The majority of balance studies in older adults have
focused on daytime assessments of stability and fall
risk.[18,19] The current study evaluated balance and sta-
bility during the night in healthy older adults with and
without administration of a sedative-hypnotic before bed.
Using the NeuroCom EquiTest SOT balance assessment,
healthy older adults exhibited no significant impairments
after a middle-of-the-night awakening compared with
pre-sleep measurements. This suggests that getting out of
bed in the middle of the night, by itself, does not affect
dynamic standing balance in healthy older adults with no
history of impaired balance. Any increase in balance prob-
lems or falls during the night in older adults might there-
fore indicate an underlying medical disorder or a
symptom of nighttime medication effects on balance
rather than a symptom of aging. However, the small sam-
ple size in this study may have prevented the detection of
small balance impairments. Also, the SOT is only
Table 1: SOT Assessments in Healthy Older Adults during the Day, Pre-Sleep, and after a Middle-of-the-Night Awakening
SOT Assessment Daytime* 
(mean ± SE)
Pre-sleep* 
(mean ± SE)
Middle-of-the-
Night* (mean ± SE)
Daytime vs Middle-
of-the-Night P value
Pre-sleep vs Middle-
of-the-Night P value
ES1 (%) 92.84 ± 0.72 94.06 ± 0.86 93.44 ± 0.86 0.594 0.617
ES2 (%) 92.27 ± 0.59 92.33 ± 0.70 92.61 ± 0.70 0.714 0.780
ES3 (%) 89.73 ± 1.29 93.22 ± 1.54 92.00 ± 1.54 0.265 0.578
ES4 (%) 76.00 ± 2.36 83.08 ± 2.81 79.39 ± 2.81 0.362 0.358
ES5 (%) 59.00 ± 3.04 65.83 ± 3.62 66.58 ± 3.62 0.117 0.884
ES6 (%) 52.31 ± 3.22 65.50 ± 3.83 60.36 ± 3.83 0.116 0.349
CES(%) 72.53 ± 1.52 79.25 ± 1.81 77.25 ± 1.81 0.053 0.439
Somatosensory Ratio 
(%)
99.47 ± 0.54 98.25 ± 0.64 99.25 ± 0.64 0.794 0.279
Visual Ratio (%) 81.94 ± 2.50 88.58 ± 2.98 85.17 ± 2.98 0.412 0.422
Vestibular Ratio (%) 63.71 ± 3.25 70.17 ± 3.87 71.25 ± 3.87 0.144 0.844
Preference Ratio (%) 94.41 ± 2.33 100.67 ± 2.77 95.92 ± 2.77 0.680 0.233
*Scores are within normal ranges for adults ≥ 65 years old.[13,14,20]
ES = equilibrium scores
CES = composite equilibrium score
Table 2: SOT Assessments Comparing Zolpidem 10 mg and Placebo after a Middle-of-the-Night Awakening
SOT Assessment Difference Between Zolpidem 10 mg and Placebo (LS mean ± SE) P value
ES1 (%) -6.67 ± 2.02 0.013
ES2 (%) -7.41 ± 1.90 0.006
ES3 (%) -6.35 ± 2.78 0.056
ES4 (%) -13.14 ± 3.76 0.010
ES5 (%) -27.69 ± 5.38 0.001
ES6 (%) -17.21 ± 3.61 0.002
CES (%) -15.83 ± 2.88 <0.001
Somatosensory Ratio (%) -1.74 ± 1.60 0.315
Visual Ratio (%) -8.76 ± 4.00 0.065
Vestibular Ratio (%) -27.43 ± 5.91 0.002
Preference Ratio (%) 12.82 ± 5.90 0.066
ES = equilibrium scores
CES = composite equilibrium scoreBMC Geriatrics 2008, 8:15 http://www.biomedcentral.com/1471-2318/8/15
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designed to measure postural control and the sensory sys-
tems associated with standing balance. It is possible that
other aspects of balance may be affected after a middle-of-
the-night awakening. The daytime assessments were also
obtained during the screening period and may be lower
due to unfamiliarity with the SOT procedures. Further
assessments comparing daytime and nighttime balance
may be needed to fully understand the time-of-day effects
on balance in older adults.
In contrast to the first pilot study, dynamic standing bal-
ance was significantly impaired during the middle of the
night after a bedtime dose of zolpidem 10 mg in the sec-
ond study. This suggests that the SOT has the ability to
measure medication-induced dynamic standing balance
impairments, since previous studies using other measures
of balance have shown significant balance impairments
and increased fall risk after zolpidem administra-
tion.[8,9,20] Even with the small number of subjects in
the current study, significant middle-of-the-night balance
impairments were detected after zolpidem administra-
tion, suggesting that zolpidem would be a good positive
control for future treatment comparison balance studies
using the SOT.
Balance was evaluated in the current study using the Neu-
roCom EquiTest SOT assessment. Several studies have
demonstrated the association between impaired SOT
equilibrium scores and the incidence of falls in adults of
all ages.[13,14,21,22] In healthy adults (mean age 45),
the incidence of multiple falls within a 3-year period was
significantly associated with lower SOT equilibrium
scores.[13] Similarly, in older adults, SOT composite
scores were significantly lower in subjects with a history of
falls compared to non-fallers.[21] The combined evidence
from these and other studies suggests that balance assess-
ment using the EquiTest SOT is a strong predictor of fall
risk.
Conclusion
In healthy older adults, getting up in the middle of the
night did not have any significant effect on dynamic
standing balance; however, bedtime administration of
zolpidem 10 mg did lead to significant deficits. The SOT
assessment successfully detected dynamic standing bal-
ance impairments due to zolpidem and may be useful for
future studies comparing balance effects of medications.
However, additional measures may be useful in assessing
other aspects of balance to gain a fuller understanding of
the effects of medications on balance.
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